Lung cancer is the leading cause of cancer death, but we have the opportunity to reduce late-stage diagnosis and reduce mortality through screening. Join us as we review the importance of a lung screening program and the toolkit NCC's Lung Cancer Collaborative developed to help get your lung screening program off the ground.
Featuring:
Lily Helzer, MPH, Cancer Prevention & Early Detection Programs Manager, Nevada Cancer Coalition
Join us for our first-ever All Member Meeting, a semi-annual virtual event designed to provide you with updates on NCC activities, opportunities to get involved, and updates in prevention, early detection and survivorship. This fast-paced meeting will include:
Screening for lung cancer with low-dose CT isn't new, but many people are still unaware of the importance of this early detection method and its ability to reduce cancer deaths. Radiologic technologist Diane Klassen from Winnemucca's Humboldt General Hospital saw the potential for increasing lung screening with LDCT in her community and developed and launched a program in just a few short months.
Christina Wu was diagnosed with breast cancer in April 2018 and felt that during her cancer journey there was something missing between discovery, diagnosis, treatment, and recovery. She founded The Remissionaries, a Las Vegas-based nonprofit, to help others going through chemotherapy treatment by providing that missing element.
Join the ACS NCCRT to learn about our latest resource, the Lead Time Messaging Guidebook: A Tool to Encourage On-Time Colorectal Cancer Screening. This guidebook is intended to provide you with information and tools to motivate individuals at average and heightened risk for colorectal cancer to discuss screening prior to the recommended screening age. During this webinar you will learn about the market research that was used to inform the tailored messaging tactics outlined in the guidebook, and hear what else is included in this new, exciting resource.
Dr. Schwartzberg is Chief, Medical Oncology and Hematology at the Pennington Cancer Institute at Reno Health and Professor of Clinical Medicine at the University of Nevada, Reno. He did his hematology/oncology fellowship at Memorial Sloan Kettering Cancer Center and spent three decades at West Cancer Center and Research Institute as Medical Director. He was Chief, Division of hematology/oncology and Professor of Medicine at the University of Tennessee Health Science center from 2012-2017.
Dr. Charles St. Hill was born and raised in San Diego, California. He attended UC Berkeley where he received a Bachelor’s degree in Molecular and Cell Biology: Immunology in 1997. After matriculating to USC’s Keck School of Medicine in 2001 for his medical doctorate, he completed a general surgery residency here in Las Vegas at the University of Nevada, Reno School of Medicine (UNR Med) in 2010. During this time, he developed a passion for the treatment of patients with cancer as well as research to improve their outcomes.
Kimberly S Johnson, MHA CPHQ has over 30 years of healthcare experience.
Dr. Mehta is the Director of Interventional Pulmonology at the Lung Center of Nevada, a division of Comprehensive Cancer Centers and also the Department Chair of Pulmonology at MountainView Hospital, both in Las Vegas, NV. He is fellowship trained in Interventional Pulmonology, which specializes in the minimally invasive diagnosis and treatment of lung conditions.
Chelsea Bishop is a native Nevadan, registered nurse and mom. Her daughter, Navy, is her inspiration in using her voice to help those going through cancer treatments.